❌

Normal view

Received — 19 December 2025 ⏭ Favourites

XTC, A Research Platform for Optimizing AI Workload Operators

✇cs.AI, q-bio.NC updates on arXiv.org
By: Pompougnac Hugo · Guillon Christophe · Noiry Sylvain · Dutilleul Alban · Iooss Guillaume · Rastello Fabrice
19 December 2025 at 13:00
arXiv:2512.16512v1 Announce Type: cross Abstract: Achieving high efficiency on AI operators demands precise control over computation and data movement. However, existing scheduling languages are locked into specific compiler ecosystems, preventing fair comparison, reuse, and evaluation across frameworks. No unified interface currently decouples scheduling specification from code generation and measurement. We introduce XTC, a platform that unifies scheduling and performance evaluation across compilers. With its common API and reproducible measurement framework, XTC enables portable experimentation and accelerates research on optimization strategies.

First, do NOHARM: towards clinically safe large language models

✇cs.AI, q-bio.NC updates on arXiv.org
By: David Wu · Fateme Nateghi Haredasht · Saloni Kumar Maharaj · Priyank Jain · Jessica Tran · Matthew Gwiazdon · Arjun Rustagi · Jenelle Jindal · Jacob M. Koshy · Vinay Kadiyala · Anup Agarwal · Bassman Tappuni · Brianna French · Sirus Jesudasen · Christopher V. Cosgriff · Rebanta Chakraborty · Jillian Caldwell · Susan Ziolkowski · David J. Iberri · Robert Diep · Rahul S. Dalal · Kira L. Newman · Kristin Galetta · J. Carl Pallais · Nancy Wei · Kathleen M. Buchheit · David I. Hong · Ernest Y. Lee · Allen Shih · Vartan Pahalyants · Tamara B. Kaplan · Vishnu Ravi · Sarita Khemani · April S. Liang · Daniel Shirvani · Advait Patil · Nicholas Marshall · Kanav Chopra · Joel Koh · Adi Badhwar · Liam G. McCoy · David J. H. Wu · Yingjie Weng · Sumant Ranji · Kevin Schulman · Nigam H. Shah · Jason Hom · Arnold Milstein · Adam Rodman · Jonathan H. Chen · Ethan Goh
19 December 2025 at 13:00
arXiv:2512.01241v2 Announce Type: replace-cross Abstract: Large language models (LLMs) are routinely used by physicians and patients for medical advice, yet their clinical safety profiles remain poorly characterized. We present NOHARM (Numerous Options Harm Assessment for Risk in Medicine), a benchmark using 100 real primary care-to-specialist consultation cases to measure frequency and severity of harm from LLM-generated medical recommendations. NOHARM covers 10 specialties, with 12,747 expert annotations for 4,249 clinical management options. Across 31 LLMs, potential for severe harm from LLM recommendations occurs in up to 22.2% (95% CI 21.6-22.8%) of cases, with harm of omission accounting for 76.6% (95% CI 76.4-76.8%) of errors. Safety performance is only moderately correlated (r = 0.61-0.64) with existing AI and medical knowledge benchmarks. The best models outperform generalist physicians on safety (mean difference 9.7%, 95% CI 7.0-12.5%), and a diverse multi-agent approach improves safety compared to solo models (mean difference 8.0%, 95% CI 4.0-12.1%). Therefore, despite strong performance on existing evaluations, widely used AI models can produce severely harmful medical advice at nontrivial rates, underscoring clinical safety as a distinct performance dimension necessitating explicit measurement.
Received — 18 December 2025 ⏭ Favourites

A Multicenter Benchmark of Multiple Instance Learning Models for Lymphoma Subtyping from HE-stained Whole Slide Images

✇cs.AI, q-bio.NC updates on arXiv.org
By: Rao Muhammad Umer · Daniel Sens · Jonathan Noll · Christian Matek · Lukas Wolfseher · Rainer Spang · Ralf Huss · Johannes Raffler · Sarah Reinke · Wolfram Klapper · Katja Steiger · Kristina Schwamborn · Carsten Marr
17 December 2025 at 13:00
arXiv:2512.14640v1 Announce Type: cross Abstract: Timely and accurate lymphoma diagnosis is essential for guiding cancer treatment. Standard diagnostic practice combines hematoxylin and eosin (HE)-stained whole slide images with immunohistochemistry, flow cytometry, and molecular genetic tests to determine lymphoma subtypes, a process requiring costly equipment, skilled personnel, and causing treatment delays. Deep learning methods could assist pathologists by extracting diagnostic information from routinely available HE-stained slides, yet comprehensive benchmarks for lymphoma subtyping on multicenter data are lacking. In this work, we present the first multicenter lymphoma benchmarking dataset covering four common lymphoma subtypes and healthy control tissue. We systematically evaluate five publicly available pathology foundation models (H-optimus-1, H0-mini, Virchow2, UNI2, Titan) combined with attention-based (AB-MIL) and transformer-based (TransMIL) multiple instance learning aggregators across three magnifications (10x, 20x, 40x). On in-distribution test sets, models achieve multiclass balanced accuracies exceeding 80% across all magnifications, with all foundation models performing similarly and both aggregation methods showing comparable results. The magnification study reveals that 40x resolution is sufficient, with no performance gains from higher resolutions or cross-magnification aggregation. However, on out-of-distribution test sets, performance drops substantially to around 60%, highlighting significant generalization challenges. To advance the field, larger multicenter studies covering additional rare lymphoma subtypes are needed. We provide an automated benchmarking pipeline to facilitate such future research.
Received — 16 December 2025 ⏭ Favourites

Generating Reliable Synthetic Clinical Trial Data: The Role of Hyperparameter Optimization and Domain Constraints

✇cs.AI, q-bio.NC updates on arXiv.org
By: Waldemar Hahn, Jan-Niklas Eckardt, Christoph R\"ollig, Martin Sedlmayr, Jan Moritz Middeke, Markus Wolfien
16 December 2025 at 13:00
arXiv:2505.05019v2 Announce Type: replace-cross Abstract: The generation of synthetic clinical trial data offers a promising approach to mitigating privacy concerns and data accessibility limitations in medical research. However, ensuring that synthetic datasets maintain high fidelity, utility, and adherence to domain-specific constraints remains a key challenge. While hyperparameter optimization (HPO) improves generative model performance, the effectiveness of different optimization strategies for synthetic clinical data remains unclear. This study systematically evaluates four HPO objectives across nine generative models, comparing single-metric to compound metric optimization. Our results demonstrate that HPO consistently improves synthetic data quality, with Tab DDPM achieving the largest relative gains, followed by TVAE (60%), CTGAN (39%), and CTAB-GAN+ (38%). Compound metric optimization outperformed single-metric objectives, producing more generalizable synthetic datasets. Despite improving overall quality, HPO alone fails to prevent violations of essential clinical survival constraints. Preprocessing and postprocessing played a crucial role in reducing these violations, as models lacking robust processing steps produced invalid data in up to 61% of cases. These findings underscore the necessity of integrating explicit domain knowledge alongside HPO to generate high-quality synthetic datasets. Our study provides actionable recommendations for improving synthetic data generation, with future work needed to refine metric selection and validate findings on larger datasets.
Received — 10 December 2025 ⏭ Favourites

Data Visualization Support for Interdisciplinary Team Treatment Planning in Clinical Oncology: Scoping Review

✇Journal of Medical Internet Research
By: Dominik Boehm · Cosima Strantz · Arsenij Ustjanzew · Iryna Manuilova · Alexander Scheiter · Thomas Pauli · Nicole Hechtel · Niklas Reimer · Jan Christoph · Hauke Busch · Thomas Ganslandt · Philipp Unberath
10 December 2025 at 05:30
Background: Complex and expanding datasets in clinical oncology applications require flexible and interactive visualization of patient data to provide physicians and other medical professionals with maximum amount of information. In particular, interdisciplinary tumor conferences profit from customized tools to integrate, link, and visualize relevant data from all professions involved. Objective: Our objective was to identify and present currently available data visualization tools for tumor boards and related areas. We wanted to provide an overview of not only the digital tools currently used in tumor board settings but also of the data they include, their respective visualization solutions, and their integration into hospital processes. Methods: This scoping review was based on the scoping study framework by Arksey and O’Malley and attempted to answer the following research question: “What are the key features of data visualization solutions used in molecular and organ tumor boards, and how are these elements integrated and used within the clinical setting?” The following electronic databases were searched for articles: PubMed, Web of Science, and Scopus. Articles were deemed eligible if published in English in the last 10 years. Eligible articles were first deduplicated, followed by screening of titles and abstracts. Full-text screening was then conducted to decide on article selection. All included articles were analyzed using a data extraction template. The template included a variety of meta-information, as well as specific fields aiming to answer the research question. Results: The review process started with 2049 articles, of which 1014 (49.49%) were included in the title and abstract screening. A total of 5.47% (112/2049) of the publications were eligible for full-text screening, leading to 2.93% (60/2049) of the publications being eligible for final inclusion. They covered 49 distinct visualization tools and applications. We discovered a variety of innovative visualization solutions, most often driven by the complexity of omics data, represented in 96% (47/49) of the tools. Tables remained the most used tool for the visualization of data types described in the articles. Approximately one-third of the identified tools (16/49, 33%) were systematically evaluated in some form. For most discovered tools (37/49, 76%), there was no documentation of implementation into the clinical routine. A significant number of applications (21/49, 43%) were available through open-source access. Conclusions: There is a wide range of projects providing visualization solutions for tumor boards and clinical oncology applications. Among the few tools that have made their way into clinical routine settings, there are both commercial and academic solutions. While tables for a variety of data types remain the dominant visualization strategy, the complexity of omics data appears to be the driving force behind many visualization innovations in the domain of tumor boards. Trial Registration:
Received — 9 December 2025 ⏭ Favourites

XR-DT: Extended Reality-Enhanced Digital Twin for Agentic Mobile Robots

✇cs.AI, q-bio.NC updates on arXiv.org
By: Tianyi Wang · Jiseop Byeon · Ahmad Yehia · Huihai Wang · Yiming Xu · Tianyi Zeng · Ziran Wang · Junfeng Jiao · Christian Claudel
8 December 2025 at 13:00
arXiv:2512.05270v1 Announce Type: cross Abstract: As mobile robots increasingly operate alongside humans in shared workspaces, ensuring safe, efficient, and interpretable Human-Robot Interaction (HRI) has become a pressing challenge. While substantial progress has been devoted to human behavior prediction, limited attention has been paid to how humans perceive, interpret, and trust robots' inferences, impeding deployment in safety-critical and socially embedded environments. This paper presents XR-DT, an eXtended Reality-enhanced Digital Twin framework for agentic mobile robots, that bridges physical and virtual spaces to enable bi-directional understanding between humans and robots. Our hierarchical XR-DT architecture integrates virtual-, augmented-, and mixed-reality layers, fusing real-time sensor data, simulated environments in the Unity game engine, and human feedback captured through wearable AR devices. Within this framework, we design an agentic mobile robot system with a unified diffusion policy for context-aware task adaptation. We further propose a chain-of-thought prompting mechanism that allows multimodal large language models to reason over human instructions and environmental context, while leveraging an AutoGen-based multi-agent coordination layer to enhance robustness and collaboration in dynamic tasks. Initial experimental results demonstrate accurate human and robot trajectory prediction, validating the XR-DT framework's effectiveness in HRI tasks. By embedding human intention, environmental dynamics, and robot cognition into the XR-DT framework, our system enables interpretable, trustworthy, and adaptive HRI.
Received — 4 December 2025 ⏭ Favourites

A Definition of AGI

✇cs.AI, q-bio.NC updates on arXiv.org
By: Dan Hendrycks · Dawn Song · Christian Szegedy · Honglak Lee · Yarin Gal · Erik Brynjolfsson · Sharon Li · Andy Zou · Lionel Levine · Bo Han · Jie Fu · Ziwei Liu · Jinwoo Shin · Kimin Lee · Mantas Mazeika · Long Phan · George Ingebretsen · Adam Khoja · Cihang Xie · Olawale Salaudeen · Matthias Hein · Kevin Zhao · Alexander Pan · David Duvenaud · Bo Li · Steve Omohundro · Gabriel Alfour · Max Tegmark · Kevin McGrew · Gary Marcus · Jaan Tallinn · Eric Schmidt · Yoshua Bengio
4 December 2025 at 13:00
arXiv:2510.18212v3 Announce Type: replace Abstract: The lack of a concrete definition for Artificial General Intelligence (AGI) obscures the gap between today's specialized AI and human-level cognition. This paper introduces a quantifiable framework to address this, defining AGI as matching the cognitive versatility and proficiency of a well-educated adult. To operationalize this, we ground our methodology in Cattell-Horn-Carroll theory, the most empirically validated model of human cognition. The framework dissects general intelligence into ten core cognitive domains-including reasoning, memory, and perception-and adapts established human psychometric batteries to evaluate AI systems. Application of this framework reveals a highly "jagged" cognitive profile in contemporary models. While proficient in knowledge-intensive domains, current AI systems have critical deficits in foundational cognitive machinery, particularly long-term memory storage. The resulting AGI scores (e.g., GPT-4 at 27%, GPT-5 at 57%) concretely quantify both rapid progress and the substantial gap remaining before AGI.
Received — 3 December 2025 ⏭ Favourites

Rethinking Lung Cancer Screening: AI Nodule Detection and Diagnosis Outperforms Radiologists, Leading Models, and Standards Beyond Size and Growth

✇cs.AI, q-bio.NC updates on arXiv.org
By: Sylvain Bodard · Pierre Baudot · Benjamin Renoust · Charles Voyton · Gwendoline De Bie · Ezequiel Geremia · Van-Khoa Le · Danny Francis · Pierre-Henri Siot · Yousra Haddou · Vincent Bobin · Jean-Christophe Brisset · Carey C. Thomson · Valerie Bourdes · Benoit Huet
2 December 2025 at 13:00
arXiv:2512.00281v1 Announce Type: cross Abstract: Early detection of malignant lung nodules is critical, but its dependence on size and growth in screening inherently delays diagnosis. We present an AI system that redefines lung cancer screening by performing both detection and malignancy diagnosis directly at the nodule level on low-dose CT scans. To address limitations in dataset scale and explainability, we designed an ensemble of shallow deep learning and feature-based specialized models. Trained and evaluated on 25,709 scans with 69,449 annotated nodules, the system outperforms radiologists, Lung-RADS, and leading AI models (Sybil, Brock, Google, Kaggle). It achieves an area under the receiver operating characteristic curve (AUC) of 0.98 internally and 0.945 on an independent cohort. With 0.5 false positives per scan at 99.3\% sensitivity, it addresses key barriers to AI adoption. Critically, it outperforms radiologists across all nodule sizes and stages, excelling in stage 1 cancers, and all growth-based metrics, including the least accurate: Volume-Doubling Time. It also surpasses radiologists by up to one year in diagnosing indeterminate and slow-growing nodules.

Human Decision-making is Susceptible to AI-driven Manipulation

✇cs.AI, q-bio.NC updates on arXiv.org
By: Sahand Sabour · June M. Liu · Siyang Liu · Chris Z. Yao · Shiyao Cui · Xuanming Zhang · Wen Zhang · Yaru Cao · Advait Bhat · Jian Guan · Wei Wu · Rada Mihalcea · Hongning Wang · Tim Althoff · Tatia M. C. Lee · Minlie Huang
2 December 2025 at 13:00
arXiv:2502.07663v3 Announce Type: replace Abstract: AI systems are increasingly intertwined with daily life, assisting users with various tasks and guiding decision-making. This integration introduces risks of AI-driven manipulation, where such systems may exploit users' cognitive biases and emotional vulnerabilities to steer them toward harmful outcomes. Through a randomized between-subjects experiment with 233 participants, we examined human susceptibility to such manipulation in financial (e.g., purchases) and emotional (e.g., conflict resolution) decision-making contexts. Participants interacted with one of three AI agents: a neutral agent (NA) optimizing for user benefit without explicit influence, a manipulative agent (MA) designed to covertly influence beliefs and behaviors, or a strategy-enhanced manipulative agent (SEMA) equipped with established psychological tactics, allowing it to select and apply them adaptively during interactions to reach its hidden objectives. By analyzing participants' preference ratings, we found significant susceptibility to AI-driven manipulation. Particularly across both decision-making domains, interacting with the manipulative agents significantly increased the odds of rating hidden incentives higher than optimal options (Financial, MA: OR=5.24, SEMA: OR=7.96; Emotional, MA: OR=5.52, SEMA: OR=5.71) compared to the NA group. Notably, we found no clear evidence that employing psychological strategies (SEMA) was overall more effective than simple manipulative objectives (MA) on our primary outcomes. Hence, AI-driven manipulation could become widespread even without requiring sophisticated tactics and expertise. While our findings are preliminary and derived from hypothetical, low-stakes scenarios, we highlight a critical vulnerability in human-AI interactions, emphasizing the need for ethical safeguards and regulatory frameworks to protect human autonomy.
Received — 21 November 2025 ⏭ Favourites

Latent plasticity of the human pancreas across development, health, and disease

✇(Multiomics OR Omics) AND (Pancreatic)
By: Elisabetta Mereu · Diego Balboa · Johannes Liebig · Aitor Gonzalez-Herrero · Anna Martinez-Casals · Mariya Mardamshina · Fanny Mollandin · Felix Schicktanz · Luca Tosti · Valerie Vandenbempt · Dana Avrahami · Edgar Bernardo · Frida Björklund · Robert Lorenz Chua · Marten Engelse · Javier García-Hurtado · Nathalie Groen · Maaike Hanegraaf · Pablo Iañez · Katharina Jechow · Björn Konukiewitz · Christian Lawerenz · Domenica Marchese · Mauro J Muraro · Silvia Pellegrini · Valeria Sordi · Alexander Sudy · Ulrike Taron · Foo Wei Ten · Timo Trefzer · Sven Twardziok · Maarten van Agen · Françoise Carlotti · Eelco de Koning · Jorge Ferrer · Benjamin Glaser · Holger Heyn · Emma Lundberg · Lorenzo Piemonti · Katja Steiger · Alexander van Oudenaarden · Wilko Weichert · Christian Conrad · Roland Eils
19 November 2025 at 19:00

bioRxiv [Preprint]. 2025 Oct 3:2025.10.01.679230. doi: 10.1101/2025.10.01.679230.

ABSTRACT

The pancreas plays a central role in major human diseases, yet our understanding of its cellular diversity and plasticity remains incomplete. Here, we present a single-cell multiomics atlas of the human pancreas, profiling over four million cells and nuclei from 57 donors across fetal development, adult homeostasis, and type 2 diabetes (T2D). Integrating sc/snRNA-seq, snATAC-seq, VASA-seq, spatial transcriptomics (Xenium), and multiplexed proteomics (CODEX), we resolve gene expression, chromatin accessibility, and spatial organization at high resolution. We identify transcriptionally plastic centroacinar-like cells (pCACs) in adults with fetal-like features, delineate endocrine and exocrine lineage trajectories during development, and uncover HNF1A-defined beta cell epigenetic states. In T2D, we observe shifts in beta cell subtypes and altered regulatory programs. Glucose perturbation of healthy islets reveals cell-type-specific adaptation and stress responses. This atlas provides a foundational framework to understand pancreas biology and the role of cellular plasticity in regeneration and disease.

PMID:41256699 | PMC:PMC12622017 | DOI:10.1101/2025.10.01.679230

Received — 18 November 2025 ⏭ Favourites

CLINB: A Climate Intelligence Benchmark for Foundational Models

✇cs.AI, q-bio.NC updates on arXiv.org
By: Michelle Chen Huebscher · Katharine Mach · Aleksandar Stani\'c · Markus Leippold · Ben Gaiarin · Zeke Hausfather · Elisa Rawat · Erich Fischer · Massimiliano Ciaramita · Joeri Rogelj · Christian Buck · Lierni Sestorain Saralegui · Reto Knutti
18 November 2025 at 13:00
arXiv:2511.11597v1 Announce Type: new Abstract: Evaluating how Large Language Models (LLMs) handle complex, specialized knowledge remains a critical challenge. We address this through the lens of climate change by introducing CLINB, a benchmark that assesses models on open-ended, grounded, multimodal question answering tasks with clear requirements for knowledge quality and evidential support. CLINB relies on a dataset of real users' questions and evaluation rubrics curated by leading climate scientists. We implement and validate a model-based evaluation process and evaluate several frontier models. Our findings reveal a critical dichotomy. Frontier models demonstrate remarkable knowledge synthesis capabilities, often exhibiting PhD-level understanding and presentation quality. They outperform "hybrid" answers curated by domain experts assisted by weaker models. However, this performance is countered by failures in grounding. The quality of evidence varies, with substantial hallucination rates for references and images. We argue that bridging this gap between knowledge synthesis and verifiable attribution is essential for the deployment of AI in scientific workflows and that reliable, interpretable benchmarks like CLINB are needed to progress towards building trustworthy AI systems.

End to End AI System for Surgical Gesture Sequence Recognition and Clinical Outcome Prediction

✇cs.AI, q-bio.NC updates on arXiv.org
By: Xi Li · Nicholas Matsumoto · Ujjwal Pasupulety · Atharva Deo · Cherine Yang · Jay Moran · Miguel E. Hernandez · Peter Wager · Jasmine Lin · Jeanine Kim · Alvin C. Goh · Christian Wagner · Geoffrey A. Sonn · Andrew J. Hung
18 November 2025 at 13:00
arXiv:2511.11899v1 Announce Type: new Abstract: Fine-grained analysis of intraoperative behavior and its impact on patient outcomes remain a longstanding challenge. We present Frame-to-Outcome (F2O), an end-to-end system that translates tissue dissection videos into gesture sequences and uncovers patterns associated with postoperative outcomes. Leveraging transformer-based spatial and temporal modeling and frame-wise classification, F2O robustly detects consecutive short (~2 seconds) gestures in the nerve-sparing step of robot-assisted radical prostatectomy (AUC: 0.80 frame-level; 0.81 video-level). F2O-derived features (gesture frequency, duration, and transitions) predicted postoperative outcomes with accuracy comparable to human annotations (0.79 vs. 0.75; overlapping 95% CI). Across 25 shared features, effect size directions were concordant with small differences (~ 0.07), and strong correlation (r = 0.96, p

Speculative Decoding in Decentralized LLM Inference: Turning Communication Latency into Computation Throughput

✇cs.AI, q-bio.NC updates on arXiv.org
By: Jingwei Song · Wanyi Chen · Xinyuan Song · Max · Chris Tong · Gufeng Chen · Tianyi Zhao · Eric Yang · Bill Shi · Lynn Ai
18 November 2025 at 13:00
arXiv:2511.11733v1 Announce Type: cross Abstract: Speculative decoding accelerates large language model (LLM) inference by using a lightweight draft model to propose tokens that are later verified by a stronger target model. While effective in centralized systems, its behavior in decentralized settings, where network latency often dominates compute, remains under-characterized. We present Decentralized Speculative Decoding (DSD), a plug-and-play framework for decentralized inference that turns communication delay into useful computation by verifying multiple candidate tokens in parallel across distributed nodes. We further introduce an adaptive speculative verification strategy that adjusts acceptance thresholds by token-level semantic importance, delivering an additional 15% to 20% end-to-end speedup without retraining. In theory, DSD reduces cross-node communication cost by approximately (N-1)t1(k-1)/k, where t1 is per-link latency and k is the average number of tokens accepted per round. In practice, DSD achieves up to 2.56x speedup on HumanEval and 2.59x on GSM8K, surpassing the Eagle3 baseline while preserving accuracy. These results show that adapting speculative decoding for decentralized execution provides a system-level optimization that converts network stalls into throughput, enabling faster distributed LLM inference with no model retraining or architectural changes.
Received — 11 November 2025 ⏭ Favourites
Received — 10 November 2025 ⏭ Favourites
Received — 6 November 2025 ⏭ Favourites

A multimodal whole-slide foundation model for pathology

✇Nature Medicine
By: Tong Ding · Sophia J. Wagner · Andrew H. Song · Richard J. Chen · Ming Y. Lu · Andrew Zhang · Anurag J. Vaidya · Guillaume Jaume · Muhammad Shaban · Ahrong Kim · Drew F. K. Williamson · Harry Robertson · Bowen Chen · Cristina Almagro-Pérez · Paul Doucet · Sharifa Sahai · Chengkuan Chen · Christina S. Chen · Daisuke Komura · Akihiro Kawabe · Mieko Ochi · Shinya Sato · Tomoyuki Yokose · Yohei Miyagi · Shumpei Ishikawa · Georg Gerber · Tingying Peng · Long Phi Le · Faisal Mahmood
5 November 2025 at 08:00

Nature Medicine, Published online: 05 November 2025; doi:10.1038/s41591-025-03982-3

Pretrained using 335,645 whole-slide images, a foundation model is developed to provide representations for slide- and patient-level tasks. It is capable of performing clinical tasks and generating reports even in data-scarce scenarios, such as rare cancer diagnosis and survival prediction, without requiring further fine-tuning.
Received — 4 November 2025 ⏭ Favourites

Digital Twin based Automatic Reconfiguration of Robotic Systems in Smart Environments

✇cs.AI, q-bio.NC updates on arXiv.org
By: Angelos Alexopoulos · Agorakis Bompotas · Nikitas Rigas Kalogeropoulos · Panagiotis Kechagias · Athanasios P. Kalogeras · Christos Alexakos
4 November 2025 at 13:00
arXiv:2511.00094v1 Announce Type: cross Abstract: Robotic systems have become integral to smart environments, enabling applications ranging from urban surveillance and automated agriculture to industrial automation. However, their effective operation in dynamic settings - such as smart cities and precision farming - is challenged by continuously evolving topographies and environmental conditions. Traditional control systems often struggle to adapt quickly, leading to inefficiencies or operational failures. To address this limitation, we propose a novel framework for autonomous and dynamic reconfiguration of robotic controllers using Digital Twin technology. Our approach leverages a virtual replica of the robot's operational environment to simulate and optimize movement trajectories in response to real-world changes. By recalculating paths and control parameters in the Digital Twin and deploying the updated code to the physical robot, our method ensures rapid and reliable adaptation without manual intervention. This work advances the integration of Digital Twins in robotics, offering a scalable solution for enhancing autonomy in smart, dynamic environments.
Received — 31 October 2025 ⏭ Favourites

The Quest for Reliable Metrics of Responsible AI

✇cs.AI, q-bio.NC updates on arXiv.org
By: Theresia Veronika Rampisela · Maria Maistro · Tuukka Ruotsalo · Christina Lioma
31 October 2025 at 12:00
arXiv:2510.26007v1 Announce Type: cross Abstract: The development of Artificial Intelligence (AI), including AI in Science (AIS), should be done following the principles of responsible AI. Progress in responsible AI is often quantified through evaluation metrics, yet there has been less work on assessing the robustness and reliability of the metrics themselves. We reflect on prior work that examines the robustness of fairness metrics for recommender systems as a type of AI application and summarise their key takeaways into a set of non-exhaustive guidelines for developing reliable metrics of responsible AI. Our guidelines apply to a broad spectrum of AI applications, including AIS.
Received — 30 October 2025 ⏭ Favourites

Multi-omic profiling reveals age-related immune dynamics in healthy adults

✇Nature - Issue - nature.com science feeds
By: Qiuyu Gong · Mehul Sharma · Marla C. Glass · Emma L. Kuan · Aishwarya Chander · Mansi Singh · Lucas T. Graybuck · Zachary J. Thomson · Christian M. LaFrance · Samir Rachid Zaim · Tao Peng · Lauren Y. Okada · Palak C. Genge · Katherine E. Henderson · Elisabeth M. Dornisch · Erik D. Layton · Peter J. Wittig · Alexander T. Heubeck · Nelson M. Mukuka · Julian Reading · Garrett Strawn · Teminijesu Titus-Adewunmi · Kathleen Abadie · Charles R. Roll · Veronica Hernandez · Vaishnavi Parthasarathy · Tyanna J. Stuckey · Blessing Musgrove · Elliott Swanson · Cara Lord · Morgan D. A. Weiss · Cole G. Phalen · Regina R. Mettey · Kevin J. Lee · John B. Johanneson · Erin K. Kawelo · Jessica Garber · Upaasana Krishnan · Megan Smithmyer · E. John Wherry · Laura A. Vella · Sarah E. Henrickson · Mackenzie S. Kopp · Adam K. Savage · Lynne A. Becker · Paul Meijer · Ernest M. Coffey · Jorg J. Goronzy · Mikael Sigvardsson · Cate Speake · Thomas F. Bumol · Ananda W. Goldrath · Troy R. Torgerson · Xiao-jun Li · Peter J. Skene · Jane H. Buckner · Claire E. Gustafson
29 October 2025 at 08:00

Nature, Published online: 29 October 2025; doi:10.1038/s41586-025-09686-5

This multi-omic longitudinal analysis of the healthy human peripheral immune system constructs the Human Immune Health Atlas and assembles data on immune cell composition and state changes with age, including responses to cytomegalovirus infection and influenza vaccination.
Received — 29 October 2025 ⏭ Favourites

Dynamic Monitoring of Recurrent Ovarian Cancer Using Serial ctDNA: A Real-World Case Series

✇MRD
By: Eric Rios-Doria · Jonathan B Reichel · Marc R Radke · Enna Manhardt · Mayumi Rubin-Saika · Christina Lockwood · Elizabeth M Swisher · Kalyan Banda
28 October 2025 at 18:00

Curr Oncol. 2025 Oct 21;32(10):585. doi: 10.3390/curroncol32100585.

ABSTRACT

Recurrent ovarian cancer (OC) is challenging to detect early using current methods like CA-125 and imaging. Circulating tumor DNA (ctDNA) may improve disease monitoring. Here, we assess the real-world clinical utility of serial ctDNA analyses in patients with recurrent OC. We analyzed serial plasma samples (N = 23) from six patients with recurrent OC using a tumor-informed next-generation sequencing assay targeting 68 cancer-related genes developed at the University of Washington. ctDNA variant allele frequencies (VAFs) were correlated with CA-125 levels, radiographic findings, and clinical outcomes. ctDNA levels generally reflected clinical status, accurately mirroring disease progression and therapeutic response. In one patient, rising ctDNA preceded clinical recurrence by four months, despite normal CA-125 and imaging, highlighting its potential advantage. Conversely, some patients exhibited clinical progression with undetectable ctDNA, indicating limitations in assay sensitivity, biological factors, or metastatic sites (e.g., brain metastases). ctDNA and CA-125 showed complementary value in most cases, suggesting potential combined use in clinical monitoring. Our findings demonstrate that ctDNA is a promising biomarker to complement existing monitoring approaches for recurrent OC. In some cases, capable of predicting relapse and treatment response ahead of current clinical indicators. However, identified discordances underscore technical and biological challenges that warrant further investigation. Larger prospective studies are necessary to refine ctDNA's clinical utility and integration into personalized OC care.

PMID:41149505 | PMC:PMC12563156 | DOI:10.3390/curroncol32100585

❌